Clincosm LogoSign in Get a demo

Influenza, Human

Showing 51 - 75 of 175
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Common Cold, Acute Respiratory Infection, Influenza, Human Trial in Russian Federation (XC8, film-coated tablets, 10 mg,

Recruiting
  • Common Cold
  • +2 more
  • XC8, film-coated tablets, 10 mg
  • Placebo
  • Ivanovo, Russian Federation
  • +5 more
May 27, 2022

Influenza, Human Trial in United States (FLU-Q-PAN H7N9 Formulation 1, FLU-Q-PAN H7N9 Formulation 2, FLU-Q-PAN H7N9 Formulation

Active, not recruiting
  • Influenza, Human
  • FLU-Q-PAN H7N9 Formulation 1
  • +5 more
  • Stockbridge, Georgia
  • +6 more
Apr 18, 2022

Virus Diseases, Pneumonia, COVID-19 Respiratory Infection Trial in Delray Beach, Zephyrhills (AlloStim)

Recruiting
  • Virus Diseases
  • +5 more
  • Delray Beach, Florida
  • +1 more
Mar 30, 2022

Common Cold, Acute Respiratory Infection, Influenza, Human Trial in Russian Federation (XC8, film-coated tablets, 20 mg/day,

Completed
  • Common Cold
  • +2 more
  • XC8, film-coated tablets, 20 mg/day
  • +3 more
  • Ivanovo, Russian Federation
  • +8 more
Feb 24, 2022

Influenza, Human, Acute Respiratory Infection, Common Cold Trial in Russian Federation (Ingavirin®, syrup, 30 mg/5 ml, Placebo)

Recruiting
  • Influenza, Human
  • +2 more
  • Ingavirin®, syrup, 30 mg/5 ml
  • Placebo
  • Odintsovo, Moscow Region, Russian Federation
  • +7 more
Feb 24, 2022

Afluria Pregnancy Registry

Completed
  • Influenza, Human
  • +2 more
  • Afluria Influenza Vaccine
  • Wilmington, North Carolina
    Syneos Health
Feb 7, 2022

ARDS, Covid19, Influenza, Human Trial (AVM0703, Placebo)

Not yet recruiting
  • ARDS
  • +2 more
  • (no location specified)
Feb 3, 2022

Influenza, Human Trial in Danville, Philadelphia (Flu shot text messages)

Completed
Has Results
  • Influenza, Human
  • Flu shot text messages
  • Danville, Pennsylvania
  • +1 more
Jan 25, 2022

Financing Strategies of Influenza Vaccination in China

Completed
  • Influenza Vaccines
  • +4 more
  • No intervention
  • Beijing, Beijing, China
  • +2 more
Jan 7, 2022

Influenza Viruses Isolated From Immunocompromised Children and

Recruiting
  • Influenza, Human
  • Blood sample
  • +4 more
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Dec 5, 2021

Influenza, Human, Pneumonia, Pneumococcal, Covid19 Trial in Chengdu, Shanghai, Taiyuan (COVAX+IIV4; COVAX+PPV23, COVAX only (1st

Completed
  • Influenza, Human
  • +2 more
  • COVAX+IIV4; COVAX+PPV23
  • +2 more
  • Chengdu, China
  • +2 more
Oct 12, 2021

Influenza, Human, Pneumonia, Pneumococcal, COVID-19 Pneumonia Trial in Guangzhou, Zhengzhou, Wuhan (COVAX+PPV23;COVAX+IIV4,

Active, not recruiting
  • Influenza, Human
  • +2 more
  • COVAX+PPV23;COVAX+IIV4
  • +2 more
  • Guangzhou, Guangdong, China
  • +2 more
Oct 5, 2021

Influenza, Human, Immune Response Trial in Pittsburgh (FluMist live attenuated influenza vaccine, Flucelvax inactivated

Completed
Has Results
  • Influenza, Human
  • Immune Response
  • FluMist live attenuated influenza vaccine
  • Flucelvax inactivated influenza vaccine
  • Pittsburgh, Pennsylvania
  • +1 more
Sep 17, 2021

Influenza, Human Trial in Hong Kong (Standard inactivated influenza vaccine (NH formulation), MF 59 adjuvanted inactivated

Active, not recruiting
  • Influenza, Human
  • Standard inactivated influenza vaccine (NH formulation)
  • +3 more
  • Hong Kong, China
    The University of Hong Kong
Sep 24, 2021

Myocardial Infarction, Influenza, Human, Influenza Vaccines Trial in Worldwide (Influenza vaccine, Placebo)

Completed
  • Myocardial Infarction
  • +4 more
  • Influenza vaccine
  • Placebo
  • Sydney, New South Wales, Australia
  • +28 more
Sep 15, 2021

Influenza, Human Trial in Hong Kong (Inactivated influenza vaccine (NH formulation), Inactivated influenza vaccine (SH

Active, not recruiting
  • Influenza, Human
  • Inactivated influenza vaccine (NH formulation)
  • +2 more
  • Hong Kong, China
    The University of Hong Kong
Sep 21, 2021

Prevalence of Influenza RelAted Invasive Aspergillosis

Recruiting
  • Invasive Pulmonary Aspergillosis
  • Influenza, Human
    • Eskilstuna, Sweden
    • +11 more
    Aug 31, 2021

    Respiratory Tract Infections, Influenza, Human, Common Cold Trial in Sacramento (Rapid respiratory pathogen nucleic acid

    Completed
    Has Results
    • Respiratory Tract Infections
    • +2 more
    • Rapid respiratory pathogen nucleic acid amplification test
    • Sacramento, California
      UC Davis Medical Center
    Apr 27, 2021

    Influenza, Human Trial in Belgium, United States (D-SUIV cH8/1N1+AS03, D-SUIV cH5/1N1+AS03, D-SUIV cH11/1N1+AS03)

    Completed
    Has Results
    • Influenza, Human
    • D-SUIV cH8/1N1+AS03
    • +10 more
    • South Miami, Florida
    • +5 more
    Apr 14, 2021

    Flucelvax (TIVc or QIVc) Pregnancy Registry

    Completed
    • Influenza, Human
    • +2 more
    • Flucelvax Trivalent Influenza Vaccine
    • Flucelvax Quadrivalent Influenza Vaccine
    • Wilmington, North Carolina
      Syneos Health
    Mar 17, 2021

    Adjuvanted Influenza Vaccination Year 2 Follow-On Survey

    Active, not recruiting
    • Influenza
    • +2 more
    • Influenza
    • Norfolk, Virginia
      Insight Therapeutics, LLC
    Mar 8, 2021

    Influenza, Human Trial in Philadelphia (Flu shot text messages)

    Completed
    • Influenza, Human
    • Flu shot text messages
    • Philadelphia, Pennsylvania
      University of Pennsylvania
    Jan 29, 2021

    Influenza, Human Trial in Cleveland (Elderberry Extract, Placebos)

    Completed
    Has Results
    • Influenza, Human
    • Elderberry Extract
    • Placebos
    • Cleveland, Ohio
      Cleveland Clinic
    Jan 13, 2021

    Influenza, Human Trial in Sherbrooke (Fluviral®)

    Completed
    Has Results
    • Influenza, Human
    • Fluviral®
    • Sherbrooke, Quebec, Canada
      GSK Investigational Site
    Oct 19, 2020

    Influenza, Human Trial in Ljubljana (Oseltamivir Oral Capsule for 5 days post-exposure, Oseltamivir Oral Capsule for 10 days

    Completed
    • Influenza, Human
    • Oseltamivir Oral Capsule for 5 days post-exposure
    • Oseltamivir Oral Capsule for 10 days post-exposure
    • Ljubljana, Slovenia
      University Medical center Ljubljana
    Nov 2, 2020